Genetic susceptibility to neurotoxicants

Clinics in Occupational and Environmental Medicine

Volumn 1, Issue 3, 2001, Pages 489-509

  Le, B T ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; ERYTHROCYTE ENZYME; HEAVY METAL; NEUROTOXIN; PESTICIDE; PLASMA PROTEIN; SOLVENT;

ARTICLE; BIOCHEMISTRY; BLOOD GROUP TYPING; CONTROLLED STUDY; DIET; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL HEALTH; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEREDITY; HLA SYSTEM; HUMAN; NUTRITIONAL STATUS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PHYSICAL ACTIVITY; RISK; TOXICOKINETICS; WORKPLACE;

EID: 0035173972     PISSN: 15260046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Translocation of protein kinase C activity may mediate hippocampal long-term potentiation
2. Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers
3. The biochemical and clinical consequences of lead poisoning
4. Lacunar infarction in patients aged 85 years and older
5. Delta-aminolevulinic acid dehydratase isozymes and lead toxicity
6. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response
7. Glutathion and N-Acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: Possible role in methylenedioxyamphetamine-mediated neurotoxicity
8. A review of recent research on health effects of human occupational exposure to organic solvents
9. Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density
10. Delta-Aminolevulinate dehydrase: A new genetic polymorphism in man
11. Delta-aminolevulinic acid dehydratase polymorphism: Influence on lead levels in kidney function in humans
12. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes
13. Plasma and blood lead in humans: Capacity-limited binding to delta-aminolevulinic acid dehydratase and other lead-binding components
14. Reversible forms of motor neuron disease
15. Electrophysiology and nerve biopsy in men exposed to lead
16. Genetic susceptibility and the common cancers
17. Genetic and environmental risk factors for Parkinson's disease in a Chinese population
18. Protein kinase C in rat brain is altered by developmental lead exposure
19. Developmental lead exposure and two-way active avoidance training alter the distribution of protein kinase C activity in the rat hippocampus
20. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis
21. Lead, inorganic
22. Lead neurotoxicity
23. Protein kinase C- a question of specificity
24. Occupational exposure to lead and blood pressure: A study of 105 workers
25. Genetic metabolic polymorphisms and the risk of cancer: A review of the literature
26. Biotransformation enzyme polymorphism and pesticide susceptibility
27. Chronic toxic encephalopathy in a painter exposed to mixed solvents
28. Effect of the delta-Aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers
29. Apolipoprotein E-epsilon 4 genotype predicts a poor outcome in survivors of traumatic brain injury
30. Chronic peripheral neuropathy produced by lead poisoning in guinea pigs
31. Genetic and temporal determinants of pesticide sensitivity: Role of Paraoxonase (PON1)
32. Relation of alleles of the sodium-potassium adenosine triphosphatase alpha 2 gene with blood pressure and lead exposure
33. Evidence that lead acts as a calcium substitute in second messenger metabolism
34. 5-Aminolevulenic acid dehydratase deficiency porphyria: A twenty-year clinical and biochemical follow-up
35. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study
36. Sex inequalities in ischaemic heart disease in general practice: Cross sectional survey
37. Association between Aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan
38. Association of lead exposure and dose measures with erythroctye protein kinase C activity in 212 current Korean lead workers
39. Frequency, clinical features and risk factors of lacunar infarction (data from a stroke registry in South India)
40. Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys
41. K x-ray fluorescence measurements of bone lead concentration: The analysis of low-level data
42. Age and secular trends in bone lead levels in middle-aged and elderly men: Three-year longitudinal follow-up in the Normative Aging Study
43. Biotransformation of xenobiotic
44. Metabolic bone disease
45. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-born heterocyclic amines increase the risk for colorectal cancer or polyps
46. Electrophysiological investigation of toxic neuropathies in man
47. Lead activates protein kinase C in immature rat brain microvessels
48. Down regulation of protein kinase C in neuronal cells: Effects of neurotransmitter release
49. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease
50. Glutathion S-transferase M (GSTM1) deficiency and lung cancer risk
51. Parkinson's disease, pesticides, and glutathion transferase polymorphisms
52. Implication of pulse pressure as a predictor of cardiac risk in patients with hypertension
53. Direct intracerebral administration of MDA and MDMA does not produce serotonin neurotoxicity
54. Prediction of bone density from vitamin D receptor alleles
55. Changes in endoneurial fluid pressure, permeability, and peripheral nerve ultrastructure in experimental lead neuropathy
56. Vitamin D receptor genotypes are related to bone size and bone density in men
57. Intracellular signaling by hydrolysis of phospholipid and activation of protein kinase C
58. The molecular heterogeneity of protein kinase C and its implications for cellular regulation
59. of+3, 4-methylenedioxymethampetamine (MDMA)
60. The genetic polymorphism of human delta-aminolevulinate dehydratase in Italy
61. The relationship between blood lead levels and blood pressure and its cardiovascular risk implication
62. Human delta-aminolevulinate dehydratase: Chromosomal localization to 9q34 by in situ hybridization
63. Impaired color discrimination among viscose rayon workers exposed to carbon disulfide
64. Cerebral complications of hypertension
65. Medical Screening of Workers
66. Relationships between distribution of lead in erythrocytes in vivo and in vitro and inhibition of ALA-D
67. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons
68. Design consideration in molecular epidemiology
69. Associations of blood lead, dimercaptosuccinic acid-cheletable lead, and tibia lead with polymorphisms in the vitamin D receptor and delta-Aminolevulinic acid dehydratase genes
70. Associations of subtypes of hemoglobin with delta-aminolevulinic acid dehydratase genotype and dimercaptosuccinic acid-chelatable lead levels
71. Association of delta-Aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoportophirin levels in Korean lead workers
72. Delta-aminolevulinic acid dehydratase genotype modifies four hours urinary lead excretion after oral administration of dimercaptosuccinic acid
73. Association of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers
74. Alzheimer's disease: Genotypes, phenotype, and treatments
75. Impairment of colour vision in workers exposed to organic solvents
76. Hypertension and stroke in Asia: Prevalence, control and strategies in developing countries for prevention
77. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers
78. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead
79. Glutathion S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy
80. Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements
81. The interaction of Apolipoprotein E genotype and tibia lead levels on neurobehavioral function in formal organolead manufacturing workers
82. Association of midlife blood pressure to late-life cognitive decline and brain morphology
83. Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama study
84. Enhance susceptibility to environmental chemicals
85. Paraoxonase polymorphisms, pesticide exposure, and Parkinson's disease in a Caucasian population
86. Renal handling of lead in dogs: Clearance studies
87. Renal excretory mechanisms of heavy metals. I. Transtubular transport of heavy metal ions in the avian kidney
88. Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: Implication for molecular screening of individuals for genetic susceptibility to lead poisoning
89. The delta-aminolevulinate dehydratase polymorphism: Higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes
90. Introduction and overview
91. Polymorphism of delta-aminolevulinic acid dehydratase in lead exposed workers
92. The interaction of triethyl lead with tubulin and microtubules